Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T15:05:49.560Z.
Calculation as of: 2026-10-06T15:05:49.560Z.
Quote observation: 2026-10-06T15:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a39ca6935a26d8aa5af55aa8ea7db8fcfa7d32011c972ec9cce8dd9481767f6
PE RATIO
N/A
BridgeBio Oncology Therapeutics Inc.
Market Cap
$293.99M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$310.71M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc. (BBOT) | $293.99M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $292.42M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | N/A | 6.29 | 6.29 | 6.29 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $304.97M | N/A | 396.83 | 396.83 | 396.83 |
| Aurora Cannabis Inc. (ACB)vs › | $278.45M | N/A | 46.08 | 46.08 | 46.08 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $310.71M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $275.74M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.67
Forward EPS (Est.)
$-2.59
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
